Product Finder

Select by:

View all products
View all news

Other Products from this Line

Inhalan Plus

Bottles containing 60 doses.


View more

Toflux

Granules x 200 mg: containers with 20 packs. Granules x 600 mg: containers with 10 and 20 packs.


View more

Vacunace

Packages containing 20 and 30 packs.

 

 


View more

Montrate

Coated tablets: Packs containing 30 coated tablets. Chewing tablets: Packs containing 30 coated tablets.


View more

Product Line:

Respiratory Line

Patient Product Information

Formulation:
7 mg capsules: each capsule for Adults contains: Standardized Lyophilized Bacterial Lysates (*) 40.000 mg; Excipients  q.s; (*): 40 mg composition of Standardized Lyophilized: Lyophilized Bacterial Lysates of: Haemophilus influenzae, Diplococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Neisseria catarrhalis 7.000 mg; Excipients  q.s; 3.5 mg capsules: each capsule for Children contains: Standardized Lyophilized Bacterial Lysates (*) 20.000 mg; Excipients  q.s; (*): 20 mg composition of Standardized Lyophilized: Lyophilized Bacterial Lysates of: Haemophilus influenzae, Diplococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Neisseria catarrhalis 3.500 mg; Excipients  q.s

Therapeutical Action:
immunostimulant agent.

Indications:
immunotherapy.Prevention of respiratory airways recurrent infections and acute infectious exacerbations of chronic bronchitis.
Adjunctive treatment of respiratory airway acute infection.

Dosage and Administration
Preventive treatment and/ or consolidation therapeutics: a daily capsule administered under fasting conditions during 10 consecutive days in a month during a total period of 3 months.
Treatment of acute episodes: a daily capsule administered under fasting conditions until the symptoms disappear (at least 10 days). When the treatment requires antibiotics simultaneous administration, the combination with BRONCHO-VAXOM is recommended from the beginning of the therapeutics.
Children from 6 months to 12 years old: The same use as for adults since BRONCHO-VAXOM “children” represents half dose of BRONCHO-VAXOM “adults”.
Note: BRONCHO-VAXOM “children” capsules may be opened and its content may be poured in a drink (fruit juice, milk, etc.) in cases in which the child has difficulties in swallowing.

Contraindications:
known hypersensitivity to BRONCHO-VAXOM components.

How-Supplied:
Adults: packages containing 10 and 30 capsules. Children: packages containing 10 and 30 capsules.